REGINA, Saskatchewan, Aug. 22, 2024 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that it has agreed to acquire from two arm’s length vendors (the “Vendors”) a 90% interest in a ph
About PharmaCorp Rx Inc. Read More